Hot Stocks: Biogen Idec Inc, Avanir Pharmaceuticals, Vertex Pharmaceuticals Incorporated, Ironwood Pharmaceuticals

Lakeway, TX -- (SBWIRE) -- 03/12/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Biogen Idec Inc.(NASDAQ:BIIB) moved up 0.75% and is trading at $175.44. Biogen Idec Inc. (Biogen Idec) is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. The Company’s products include AVONEX, TYSABRI, FAMPYRA, FUMADERM and RITUXAN. In September 2011, the Company acquired from the Dompe Group the noncontrolling interests in its joint venture sales affiliates in Italy and Switzerland.

How Should Investors Trade BIIB After The Recent Movement? Find Out Here

Avanir Pharmaceuticals, Inc.(NASDAQ:AVNR) is lower 3.47% and is trading at $2.92. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas. Its docosanol 10% cream, sold in the United States and Canada as Abreva by its marketing partner GlaxoSmithKline Consumer Healthcare, is the only over-the-counter treatment for cold sores that has been approved by the United Sates Food and Drug Administration (FDA).

Is AVNR Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Vertex Pharmaceuticals Incorporated(NASDAQ:VRTX) moved down 0.95% and is trading at $52.05. Vertex Pharmaceuticals Incorporated (Vertex) is in the business of discovering, developing, manufacturing and commercializing small molecule drugs for the treatment of serious diseases.

Is VRTX a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Ironwood Pharmaceuticals, Inc.(NASDAQ:IRWD) is higher 0.06% and is trading at $17.19. Ironwood Pharmaceuticals, Inc. is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines. The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal diseases. Its two GC-C agonists are linaclotide and IW-9179.

How Should Investors Trade IRWD After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.